MSLN CAR mRNA-LNP

Cat. No.: TDLD-0825-LD42

MSLN CAR mRNA-LNP

MSLN CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting Mucin 1 C-terminal Subunit Protein (MSLN), serving as an excellent tool for investigating CAR-T cell therapy against MSLN-expressing cancers like mesothelioma, pancreatic cancer, and ovarian cancer, and studying receptor-specific immune modulation. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of MSLN CAR mRNA-LNP include monitoring CAR expression on transduced T cells and evaluating CAR-T cell functionality against MSLN-positive targets. Please note that this product is intended for research purposes only.